Jon Chesebrough
Impact in
-
- CAR-T cell therapy research
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
-
- Immunotherapy and Immune Responses
Papers in
-
- Angiogenesis and VEGF in Cancer 1
- Heat shock proteins research 1
- Ubiquitin and proteasome pathways 1
- Oncology 5
- CAR-T cell therapy research 3
- Cancer Immunotherapy and Biomarkers 2
- Lung Cancer Research Studies 1
- Co-authors
- Robert E. Hollingsworth (3 shared papers)Leslie Wetzel (3 shared papers)Raymond Rothstein (3 shared papers)Jonathan Rios‐Doria (3 shared papers)Ching Ching Leow (4 shared papers)Nicholas Holoweckyj (2 shared papers)Wei Zhao (1 shared paper)Nicholas M. Durham (1 shared paper)
- Journals
- Cancer Research (4 papers)Molecular Cancer Therapeutics (2 papers)Journal of Biological Chemistry (1 paper)Cytotherapy (1 paper)Neoplasia (1 paper)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Jon Chesebrough
9 papers receiving 432 citations
Peers
Comparison fields: 5 of 55
- Oncology 198
- Immunology 108
- Endocrinology, Diabetes and Metabolism 72
- Radiology, Nuclear Medicine and Imaging 79
- Biomaterials 41
Countries citing papers authored by Jon Chesebrough
This map shows the geographic impact of Jon Chesebrough's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Chesebrough with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Chesebrough more than expected).
Fields of papers citing papers by Jon Chesebrough
This network shows the impact of papers produced by Jon Chesebrough. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Chesebrough. The network helps show where Jon Chesebrough may publish in the future.
Co-authors
The 25 scholars most cited alongside Jon Chesebrough, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 155 | |
| 2 | 2011 | 108 | |
| 3 | 2017 | 103 | |
| 4 | 2001 | 39 | |
| 5 | 2009 | 34 | |
| 6 | 2022 | 8 | |
| 7 | 2013 | 2 | |
| 8 | 2017 | 1 | |
| 9 | 2013 | 1 | |
| 10 | 2020 | 1 |
About Jon Chesebrough
Jon Chesebrough is a scholar working on Molecular Biology, Oncology, Immunology, Cancer Research and Organic Chemistry, having authored 10 papers that have together received 452 indexed citations. Recurring topics across this work include CAR-T cell therapy research (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Angiogenesis and VEGF in Cancer (1 paper), Lung Cancer Research Studies (1 paper), Heat shock proteins research (1 paper), Ubiquitin and proteasome pathways (1 paper) and Enzyme Structure and Function (1 paper). The work is most often cited by research in Oncology (198 citations), Immunology (108 citations), Endocrinology, Diabetes and Metabolism (72 citations), Radiology, Nuclear Medicine and Imaging (79 citations) and Biomaterials (41 citations). Jon Chesebrough has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Robert E. Hollingsworth, Leslie Wetzel, Raymond Rothstein, Jonathan Rios‐Doria, Ching Ching Leow, Nicholas Holoweckyj, Wei Zhao, Nicholas M. Durham, Bahija Jallal and Yong S. Chang. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Journal of Biological Chemistry, Cytotherapy and Neoplasia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.